...
search icon
carm-img

Carisma Therapeutics Inc., Common Stock

CARM

NMQ

$0.4712

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$19.67M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
190.18K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.38 L
$2.77 H
$0.4712

About Carisma Therapeutics Inc., Common Stock

Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company's ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phase 1 clinical trial to treat solid tumors; CT-0525, a CAR-monocyte that is in Phase 1 clinical trial to treat solid tumors; and CT-1119, a mesothelin-targeted CAR-Monocyte that is in pre-clinical stage to treat patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. It is also developing in vivo CAR-M cell therapies in collaboration with Moderna Therapeutics to address multiple cancer targets; and multiple assets for the potential treatment of diseases beyond oncology, including fibrosis and other immunologic and inflammatory diseases. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCARMSectorS&P500
1-Week Return-10.77%0.49%-0.42%
1-Month Return-31.98%-3.1%-2.2%
3-Month Return-49.5%-8.59%2.38%
6-Month Return-59.03%-4.57%5.1%
1-Year Return-82.93%-0.94%23.79%
3-Year Return-97.13%2.88%26.66%
5-Year Return-97.67%35.84%81.16%
10-Year Return-99.82%98.8%191.72%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-11.24M26.54M9.83M14.92M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":42.33,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":37.05,"profit":true},{"date":"2023-12-31","value":56.2,"profit":true}]
Cost of Revenue219.00K-85.00K6.09M74.13M[{"date":"2019-12-31","value":0.3,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.11,"profit":true},{"date":"2022-12-31","value":8.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(219.00K)11.24M26.46M3.74M(59.21M)[{"date":"2019-12-31","value":-0.83,"profit":false},{"date":"2020-12-31","value":42.47,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":14.15,"profit":true},{"date":"2023-12-31","value":-223.77,"profit":false}]
Gross Margin-100.00%99.68%38.07%(396.85%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.68,"profit":true},{"date":"2022-12-31","value":38.07,"profit":true},{"date":"2023-12-31","value":-396.85,"profit":false}]
Operating Expenses36.65M28.38M40.79M59.91M103.65M[{"date":"2019-12-31","value":35.36,"profit":true},{"date":"2020-12-31","value":27.38,"profit":true},{"date":"2021-12-31","value":39.36,"profit":true},{"date":"2022-12-31","value":57.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(36.87M)(28.38M)(40.79M)(56.16M)(88.73M)[{"date":"2019-12-31","value":-3687100000,"profit":false},{"date":"2020-12-31","value":-2837800000,"profit":false},{"date":"2021-12-31","value":-4079400000,"profit":false},{"date":"2022-12-31","value":-5616200000,"profit":false},{"date":"2023-12-31","value":-8873100000,"profit":false}]
Total Non-Operating Income/Expense-58.00K20.00K(8.21M)3.79M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":1.53,"profit":true},{"date":"2021-12-31","value":0.53,"profit":true},{"date":"2022-12-31","value":-216.71,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(107.50M)(28.35M)(40.78M)(61.23M)(86.88M)[{"date":"2019-12-31","value":-10750000000,"profit":false},{"date":"2020-12-31","value":-2834900000,"profit":false},{"date":"2021-12-31","value":-4078400000,"profit":false},{"date":"2022-12-31","value":-6122600000,"profit":false},{"date":"2023-12-31","value":-8687900000,"profit":false}]
Income Taxes-(29.00K)(10.00K)(3.88M)8.10M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.36,"profit":false},{"date":"2021-12-31","value":-0.12,"profit":false},{"date":"2022-12-31","value":-47.86,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-(28.32M)(40.77M)(57.35M)(94.98M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2832000000,"profit":false},{"date":"2021-12-31","value":-4077400000,"profit":false},{"date":"2022-12-31","value":-5735100000,"profit":false},{"date":"2023-12-31","value":-9497610500,"profit":false}]
Income From Continuous Operations-(28.35M)(40.78M)(61.23M)(86.88M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2834900000,"profit":false},{"date":"2021-12-31","value":-4078400000,"profit":false},{"date":"2022-12-31","value":-6122600000,"profit":false},{"date":"2023-12-31","value":-8687900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(107.50M)(28.32M)(40.77M)(61.23M)(86.88M)[{"date":"2019-12-31","value":-10750000000,"profit":false},{"date":"2020-12-31","value":-2832000000,"profit":false},{"date":"2021-12-31","value":-4077400000,"profit":false},{"date":"2022-12-31","value":-6122600000,"profit":false},{"date":"2023-12-31","value":-8687900000,"profit":false}]
EPS (Diluted)(24.00)(4.60)(2.00)(2.08)(3.47)[{"date":"2019-12-31","value":-2400,"profit":false},{"date":"2020-12-31","value":-460,"profit":false},{"date":"2021-12-31","value":-200,"profit":false},{"date":"2022-12-31","value":-208.09,"profit":false},{"date":"2023-12-31","value":-347,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CARM
Cash Ratio 2.55
Current Ratio 3.23

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CARM
ROA (LTM) -56.08%
ROE (LTM) -362.79%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CARM
Debt Ratio Lower is generally better. Negative is bad. 1.26
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.26

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CARM
Trailing PE NM
Forward PE NM
P/S (TTM) 0.97
P/B 114.10
Price/FCF NM
EV/R 0.43
EV/Ebitda NM

FAQs

What is Carisma Therapeutics Inc. share price today?

Carisma Therapeutics Inc. (CARM) share price today is $0.4712

Can Indians buy Carisma Therapeutics Inc. shares?

Yes, Indians can buy shares of Carisma Therapeutics Inc. (CARM) on Vested. To buy Carisma Therapeutics Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CARM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Carisma Therapeutics Inc. be purchased?

Yes, you can purchase fractional shares of Carisma Therapeutics Inc. (CARM) via the Vested app. You can start investing in Carisma Therapeutics Inc. (CARM) with a minimum investment of $1.

How to invest in Carisma Therapeutics Inc. shares from India?

You can invest in shares of Carisma Therapeutics Inc. (CARM) via Vested in three simple steps:

  • Click on Sign Up or Invest in CARM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Carisma Therapeutics Inc. shares
What is Carisma Therapeutics Inc. 52-week high and low stock price?

The 52-week high price of Carisma Therapeutics Inc. (CARM) is $2.77. The 52-week low price of Carisma Therapeutics Inc. (CARM) is $0.38.

What is Carisma Therapeutics Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Carisma Therapeutics Inc. (CARM) is

What is Carisma Therapeutics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Carisma Therapeutics Inc. (CARM) is 114.10

What is Carisma Therapeutics Inc. dividend yield?

The dividend yield of Carisma Therapeutics Inc. (CARM) is 0.00%

What is the Market Cap of Carisma Therapeutics Inc.?

The market capitalization of Carisma Therapeutics Inc. (CARM) is $19.67M

What is Carisma Therapeutics Inc.’s stock symbol?

The stock symbol (or ticker) of Carisma Therapeutics Inc. is CARM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top